Tamara Hershey

Tamara Hershey

Auto-generated profile, based on publicly available information

Tamara Hershey

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2014 in Nature Photonics
Verified
Journal Article
Closed access
PDF file
AEAdam Eggebrecht
Adam Eggebrecht
SFSilvina L. Ferradal
Silvina L. Ferradal
ARAmy Robichaux-Viehoever
Amy Robichaux-Viehoever
MHMahlega S. Hassanpour
Mahlega S. Hassanpour
HDHamid Dehghani
Hamid Dehghani
JCJoseph P. Culver
Joseph P. Culver

1 February 1999 in Neuropsychopharmacology
Verified
Journal Article
Closed access
JNJ W Newcomer
J W Newcomer
NFN B Farber
N B Farber
VJV Jevtovic-Todorovic
V Jevtovic-Todorovic
GSG Selke
G Selke
AMA K Melson
A K Melson
JOJ W Olney
J W Olney

1 April 1992 in American Journal of Psychiatry
Verified
Journal Article
Closed access
JWJ C Wu
J C Wu
JGJ C Gillin
J C Gillin
MBM S Buchsbaum
M S Buchsbaum
THT Hershey
T Hershey
JJJ C Johnson
J C Johnson
WBW E Bunney
W E Bunney

1 September 2007 in Diabetes Care
Verified
Journal Article
Open access
PDF file
DPDana C. Perantie
Dana C. Perantie
JWJenny Wu
Jenny Wu
JKJonathan M. Koller
Jonathan M. Koller
ALAudrey Lim
Audrey Lim
SWStacie L. Warren
Stacie L. Warren
THTamara Hershey
Tamara Hershey
OBJECTIVE—Despite interest in the effects of type 1 diabetes on the developing brain, structural brain volumes in youth with this disease have not previously been examined. This study is the first to quantify regional brain volume differences in a large sample of youth with diabetes. RESEARCH DESIGN AND METHODS—Magnetic resonance images (MRIs) were acquired from youth with diabetes (n = 108) and healthy sibling control subjects (n = 51) aged 7–17 years. History of severe hypoglycemia was assessed by parent interview and included seizure, loss of consciousness, or requiring assistance to treat. A1C values since diagnosis were obtained from medical records; median A1C was weighted by duration of disease. Voxel-based morphometry was used to determine the relationships of prior hypo- and hyperglycemia to regional grey and white matter volumes across the whole brain. RESULTS—No significant differences were found between diabetic and healthy control groups in grey or white matter. However, within the diabetic group, a history of severe hypoglycemia was associated with smaller grey matter volume in the left superior temporal region. Greater exposure to hyperglycemia was associated with smaller grey matter volume in the right cuneus and precuneus, smaller white matter volume in a right posterior parietal region, and larger grey matter volume in a right prefrontal region. CONCLUSIONS—Qualitatively different relationships were found between hypo- and hyperglycemia and regional brain volumes in youth with type 1 diabetes. Future studies should investigate whether these differences relate to cognitive function and how these regions are affected by further exposure.

24 January 2008 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
DPDana C Perantie
Dana C Perantie
ALAudrey Lim
Audrey Lim
JWJenny Wu
Jenny Wu
PWPatrick Weaver
Patrick Weaver
SWStacie L Warren
Stacie L Warren
THTamara Hershey
Tamara Hershey
Objective: Despite the general consensus that youth with type 1 diabetes mellitus (T1DM) can experience modest cognitive impairment, debate continues over the role of severe hypoglycemia (Hypo) and/or hyperglycemia (Hyper) in producing such impairment. Our aim was to determine how Hypo and Hyper experienced during brain development predict patterns of subsequent cognitive performance in youth with T1DM. Methods: We tested youth aged 5–16 yr (T1DM, n = 117; non‐diabetic sibling controls, n = 58) on cognitive tasks (verbal and spatial intelligence, verbal and spatial memory, and processing speed). T1DM participants were categorized as having experienced 0, 1–2, or 3 or more (3+) Hypo episodes, as having their first Hypo episode before or after 5 yr of age and as having early (before age 5) or late (after age 5) diabetes onset. Hyper exposure was estimated with median hemoglobin A1c, adjusted for diabetes duration for each subject. Results: The group with T1DM had lower estimated verbal intelligence than sibling controls. Within the T1DM group, verbal intelligence was reduced with increased exposure to Hyper, not to Hypo. In contrast, spatial intelligence and delayed recall were reduced only with repeated Hypo, particularly when Hypo episodes occurred before the age of 5 yr. Age of onset did not explain these results. Conclusions: Hypo and Hyper have qualitatively different effects on cognitive function in T1DM that depend in part on the timing of exposure during development, independent of onset age. This information extends the known benefits of avoiding both Hypo and chronic Hyper during childhood to include preservation of specific cognitive skills.

24 November 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLSimin Lu
Simin Lu
KKKohsuke Kanekura
Kohsuke Kanekura
THTakashi Hara
Takashi Hara
JMJana Mahadevan
Jana Mahadevan
LSLarry D. Spears
Larry D. Spears
FUFumihiko Urano
Fumihiko Urano
Wolfram syndrome is a genetic disorder characterized by diabetes and neurodegeneration and considered as an endoplasmic reticulum (ER) disease. Despite the underlying importance of ER dysfunction in Wolfram syndrome and the identification of two causative genes, Wolfram syndrome 1 (WFS1) and Wolfram syndrome 2 (WFS2), a molecular mechanism linking the ER to death of neurons and β cells has not been elucidated. Here we implicate calpain 2 in the mechanism of cell death in Wolfram syndrome. Calpain 2 is negatively regulated by WFS2, and elevated activation of calpain 2 by WFS2-knockdown correlates with cell death. Calpain activation is also induced by high cytosolic calcium mediated by the loss of function of WFS1. Calpain hyperactivation is observed in the WFS1 knockout mouse as well as in neural progenitor cells derived from induced pluripotent stem (iPS) cells of Wolfram syndrome patients. A small-scale small-molecule screen targeting ER calcium homeostasis reveals that dantrolene can prevent cell death in neural progenitor cells derived from Wolfram syndrome iPS cells. Our results demonstrate that calpain and the pathway leading its activation provides potential therapeutic targets for Wolfram syndrome and other ER diseases. Significance Wolfram syndrome is an autosomal recessive disorder characterized by juvenile diabetes and neurodegeneration, and is considered a prototype of human endoplasmic reticulum (ER) disease. Wolfram syndrome is caused by loss of function mutations of Wolfram syndrome 1 or Wolfram syndrome 2 genes, which encode transmembrane proteins localized to the ER. Despite its rarity, Wolfram syndrome represents the best human disease model currently available to identify drugs and biomarkers associated with ER health. Furthermore, this syndrome is ideal for studying the mechanisms of ER stress-mediated death of neurons and β cells. Here we report that the pathway leading to calpain activation offers potential drug targets for Wolfram syndrome and substrates for calpain might serve as biomarkers for this syndrome.